≡ Risteys
R9

Documentation Changelog GitHub Contact & Feedback

Acrodermatitis continua

DOID EFO MESH SNOMED PheWeb

L12_PSORI_ACRODERM

psoriasis: An autoimmune condition characterized by red, well-delineated plaques with silvery scales that are usually on the extensor surfaces and scalp. They can occasionally present with these manifestations: pustules; erythema and scaling in intertriginous areas, and erythroderma, that are often distributed on extensor surfaces and scalp.

Endpoint definition

↥
FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 L40.2
Hospital discharge: ICD-9 6961C
Hospital discharge: ICD-8 68696
Cause of death: ICD-10 L40.2
Cause of death: ICD-9 6961C
Cause of death: ICD-8 68696

2 out of 7 registries used, show all original rules.

56

diagram downward connector

Check minimum number of events None

56

diagram downward connector

Include endpoints None

56

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

55

diagram downward connector
L12_PSORI_ACRODERM

Control definitions

Control exclude L12_PAPULOSQUAMOUS

Extra metadata

Level in the ICD hierarchy 4
First used in FinnGen datafreeze DF2
Parent code in ICD-10 L40
Name in latin Acrodermatitis continua (Hallopeau)

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 55 34 21
Unadjusted prevalence (%) 0.01 0.02 0.01
Mean age at first event (years) 52.99 51.49 55.42

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: L12_PSORI_ACRODERM – Acrodermatitis continua
GWS hits:

Survival analyses between endpoints

↥

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Acrodermatitis continua

↥

Endpoint not on priority list, no data to show.